Your session is about to expire
← Back to Search
Multivitamin/Mineral Supplement
Redoxon VI for Vitamin D Deficiency
N/A
Waitlist Available
Led By Adrian F Gombart, PhD
Research Sponsored by Oregon State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights
Study Summary
This trial will test if a multivitamin/mineral supplement can help older adults' immune cells better kill bacteria.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
S. aureus clearance from whole blood
Secondary outcome measures
Determine phagocytic activity of neutrophils by measuring uptake of fluorescently labeled Escherichia coli using flow cytometry
Number of neutrophils, monocytes and lymphocytes
Serum levels of inflammatory cytokines
+2 moreTrial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Redoxon VIExperimental Treatment1 Intervention
2 film coated tablets Redoxon VI oral intake daily for 12 weeks
Group II: PlaceboPlacebo Group1 Intervention
2 film coated tablets placebo oral intake daily for 12 weeks
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Redoxon VI
2016
N/A
~50
Find a Location
Who is running the clinical trial?
Oregon State UniversityLead Sponsor
49 Previous Clinical Trials
8,339 Total Patients Enrolled
Adrian F Gombart, PhDPrincipal InvestigatorPrincipal Investigator
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger